About Noretsa Pharmaceuticals Private Limited
Data last updated:
Noretsa Pharmaceuticals Private Limited is a private limited company based in Thrissur, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U74999KL2018PTC055396. Its GSTIN is 32AAGCN2756F1ZN (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Abhilash Thattarampilly (Managing Director) and Rajarajan Chennat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 101D – Ward Thattarampilly House Adat P O Nr Ambalamkav Adat, Thrissur, Kerala, India – 680551.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.73 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹3.04 Lakh (net margin 1.1%) and EBITDA of ₹12.36 Lakh (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 27% over five years.
As per MCA filings, the company has open charges of ₹25 Lakh on record.
For more details, the company can be reached via its website noretsa.com.
Company details
Contact details
Noretsa Pharmaceuticals Private Limited's registered office is in Thrissur, Kerala. Its website is noretsa.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address101D – Ward Thattarampilly House Adat P O Nr Ambalamkav Adat, Thrissur, Kerala, India – 680551
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Noretsa Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Noretsa Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Noretsa Pharmaceuticals Private Limited, buy the company report.
Financials of Noretsa Pharmaceuticals Private Limited
FY 2025 filings availableNoretsa Pharmaceuticals Private Limited reported revenue of ₹2.73 Cr (up 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 1% growth in the latest year. EBITDA fell 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.36 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.04 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Noretsa Pharmaceuticals Private Limited, buy the company report.
Board of directors of Noretsa Pharmaceuticals Private Limited
Noretsa Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhilash Thattarampilly | Managing Director | 02 Nov 2018 | 8 Years 0 Months | Current |
| Rajarajan Chennat | Director | 02 Nov 2018 | 8 Years 0 Months | Current |
| Mundankodi Ramadasan | Director | 02 Nov 2018 | 8 Years 0 Months | Current |
Auditor
Noretsa Pharmaceuticals Private Limited is audited by BIJU & BIJU for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BIJU & BIJU | FY 2022 | 009088S |
Shareholding
The shareholding of Noretsa Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Noretsa Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Oct 2024 | 101009445 | State Bank of India | ₹25 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Noretsa Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Noretsa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Noretsa Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAGCN2756F1ZN | Kerala | Active | 18 Jan 2019 |
To see the full GST registrations and return filing status of Noretsa Pharmaceuticals Private Limited, buy the company report.
Recent activity
Noretsa Pharmaceuticals Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Abhilash Thattarampilly was appointed as Managing Director on 02 Nov 2018.
Frequently asked questions
Noretsa Pharmaceuticals is an active private limited company based in Thrissur, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 November 2018 (8+ years old) and is registered under CIN U74999KL2018PTC055396.
Noretsa Pharmaceuticals has 3 current directors:
- Abhilash Thattarampilly - Managing Director
- Rajarajan Chennat - Director
- Mundankodi Ramadasan - Director
The latest financial statements of Noretsa Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Noretsa Pharmaceuticals is 32AAGCN2756F1ZN, registered in Kerala.
The CIN (Corporate Identification Number) of Noretsa Pharmaceuticals is U74999KL2018PTC055396. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Noretsa Pharmaceuticals was incorporated on 02 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ernakulam.
Abhilash Thattarampilly was appointed as Managing Director on 02 Nov 2018. Mundankodi Ramadasan was appointed as Director on 02 Nov 2018. Rajarajan Chennat was appointed as Director on 02 Nov 2018.
Noretsa Pharmaceuticals can be reached through the website noretsa.com. Its registered office is in Thrissur, Kerala, India.
The registered office of Noretsa Pharmaceuticals is at 101D – Ward Thattarampilly House Adat P O Nr Ambalamkav Adat, Thrissur, Kerala, India – 680551.
Noretsa Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
